|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-1-6
|
|
pubmed:abstractText |
The mechanisms underlying the aggravation or development of hypertension frequently seen during treatment of renal anemia with epoetins are not fully elucidated. The aim of the present study was to investigate the effects of epoetin alfa on endothelial vasodilatory function in patients with renal anemia and in healthy subjects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1660-2110
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
2006 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
c30-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16166804-Adult,
pubmed-meshheading:16166804-Anemia,
pubmed-meshheading:16166804-Blood Pressure,
pubmed-meshheading:16166804-Endothelium, Vascular,
pubmed-meshheading:16166804-Erythropoietin,
pubmed-meshheading:16166804-Female,
pubmed-meshheading:16166804-Forearm,
pubmed-meshheading:16166804-Hematinics,
pubmed-meshheading:16166804-Humans,
pubmed-meshheading:16166804-Injections, Intravenous,
pubmed-meshheading:16166804-Male,
pubmed-meshheading:16166804-Recombinant Proteins,
pubmed-meshheading:16166804-Regional Blood Flow,
pubmed-meshheading:16166804-Vasodilation
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects.
|
|
pubmed:affiliation |
Department of Medical Sciences, University Hospital, Uppsala, Sweden. Margus.Annuk@medsci.uu.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
